Furthermore, the p38 MAPK inhibitor SB203580 was revealed to suppress MCP-1 production in melanoma cells, and as with AH23848, SB203580 abrogated MCP-1 upregulation caused by TNF-α or exogenous PGE2 (Fig. 5D). This evidence concerns the gene CCL2 and melanoma.